• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏免疫蛋白酶体的小鼠在抗原呈递方面表现出重大变化。

Mice completely lacking immunoproteasomes show major changes in antigen presentation.

机构信息

Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

出版信息

Nat Immunol. 2011 Dec 25;13(2):129-35. doi: 10.1038/ni.2203.

DOI:10.1038/ni.2203
PMID:22197977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3262888/
Abstract

The importance of immunoproteasomes to antigen presentation has been unclear because animals totally lacking immunoproteasomes had not been available. Having now developed mice lacking the three immunoproteasome catalytic subunits, we found that the dendritic cells of these mice had defects in presenting several major histocompatibility complex (MHC) class I epitopes. During viral infection in vivo, the presentation of a majority of MHC class I epitopes was markedly reduced in immunoproteasome-deficient animals compared with wild-type animals, whereas presentation of MHC class II peptides was unaffected. According to mass spectrometry, the repertoire of MHC class I-presented peptides was ∼50% different from that in wild-type mice, and these differences were sufficient to stimulate robust transplant rejection of wild-type cells in mutant mice. These results indicated that immunoproteasomes were more important in antigen presentation than previously thought.

摘要

免疫蛋白酶体对于抗原呈递的重要性一直不清楚,因为缺乏完全缺乏免疫蛋白酶体的动物。现在已经开发出缺乏三种免疫蛋白酶体催化亚基的小鼠,我们发现这些小鼠的树突状细胞在呈现几种主要组织相容性复合物 (MHC) Ⅰ类表位时存在缺陷。在体内病毒感染期间,与野生型动物相比,免疫蛋白酶体缺陷动物中大多数 MHC Ⅰ类表位的呈递明显减少,而 MHC Ⅱ类肽的呈递不受影响。根据质谱分析,MHC Ⅰ类呈递肽的谱大约有 50%与野生型小鼠不同,这些差异足以刺激突变小鼠中对野生型细胞的强烈移植排斥反应。这些结果表明,免疫蛋白酶体在抗原呈递中的作用比以前认为的更为重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/9061f7e5db20/nihms341506f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/c2aff4a5fbe6/nihms341506f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/f383be6fae67/nihms341506f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/cd95c6bdc623/nihms341506f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/ae65fc953ef4/nihms341506f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/29a969fbaa01/nihms341506f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/9061f7e5db20/nihms341506f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/c2aff4a5fbe6/nihms341506f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/f383be6fae67/nihms341506f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/cd95c6bdc623/nihms341506f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/ae65fc953ef4/nihms341506f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/29a969fbaa01/nihms341506f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d429/3262888/9061f7e5db20/nihms341506f6.jpg

相似文献

1
Mice completely lacking immunoproteasomes show major changes in antigen presentation.缺乏免疫蛋白酶体的小鼠在抗原呈递方面表现出重大变化。
Nat Immunol. 2011 Dec 25;13(2):129-35. doi: 10.1038/ni.2203.
2
Impact of the TAP-like transporter in antigen presentation and phagosome maturation.TAP 样转运体在抗原呈递和吞噬体成熟中的作用。
Mol Immunol. 2019 Sep;113:75-86. doi: 10.1016/j.molimm.2018.06.268. Epub 2018 Jun 23.
3
Proteasome isoforms exhibit only quantitative differences in cleavage and epitope generation.蛋白酶体同工型仅在切割和表位生成方面表现出定量差异。
Eur J Immunol. 2014 Dec;44(12):3508-21. doi: 10.1002/eji.201444902. Epub 2014 Nov 20.
4
Immunoproteasomes: structure, function, and antigen presentation.免疫蛋白酶体:结构、功能与抗原呈递。
Prog Mol Biol Transl Sci. 2012;109:75-112. doi: 10.1016/B978-0-12-397863-9.00003-1.
5
Towards a systems understanding of MHC class I and MHC class II antigen presentation.朝着 MHC Ⅰ类和 MHC Ⅱ类抗原呈递的系统理解发展。
Nat Rev Immunol. 2011 Nov 11;11(12):823-36. doi: 10.1038/nri3084.
6
Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.用体外转录的MUC1 RNA转染后,树突状细胞对HLA I类和II类表位的加工与呈递
Blood. 2005 Apr 15;105(8):3199-205. doi: 10.1182/blood-2004-09-3556. Epub 2004 Dec 23.
7
Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.细菌抗原递呈系统:细菌抗原的吞噬加工,用于MHC-I和MHC-II呈递给T细胞。
Behring Inst Mitt. 1997 Feb(98):197-211.
8
Standard and immunoproteasomes show similar peptide degradation specificities.标准蛋白酶体和免疫蛋白酶体显示出相似的肽降解特异性。
Eur J Immunol. 2014 Dec;44(12):3500-3. doi: 10.1002/eji.201445272.
9
Alternative pathways for MHC class I presentation: a new function for autophagy.MHC Ⅰ类分子呈递的替代途径:自噬的新功能。
Cell Mol Life Sci. 2011 May;68(9):1533-41. doi: 10.1007/s00018-011-0660-3. Epub 2011 Mar 10.
10
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.肿瘤抗原的加工和呈递严重依赖于树突状细胞的类型以及抗原递呈的方式。
Blood. 2005 Mar 15;105(6):2465-72. doi: 10.1182/blood-2004-08-3105. Epub 2004 Nov 16.

引用本文的文献

1
The Immunoproteasome Is Expressed but Dispensable for a Leukemia Infected Cell Vaccine.免疫蛋白酶体在白血病感染细胞疫苗中表达但并非必需。
Vaccines (Basel). 2025 Aug 5;13(8):835. doi: 10.3390/vaccines13080835.
2
Current landscape of the immunoproteasome: implications for disease and therapy.免疫蛋白酶体的当前态势:对疾病与治疗的影响
Cell Death Discov. 2025 Aug 25;11(1):406. doi: 10.1038/s41420-025-02698-0.
3
Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities.非小细胞肺癌中的免疫治疗耐药性:从机制到治疗机遇

本文引用的文献

1
Utility of characteristic QTOF MS/MS fragmentation for MHC class I peptides.特征 QTOF MS/MS 碎裂在 MHC Ⅰ类肽中的应用。
J Proteome Res. 2011 May 6;10(5):2494-507. doi: 10.1021/pr101272k. Epub 2011 Mar 30.
2
Maturation-dependent licensing of naive T cells for rapid TNF production.幼稚 T 细胞成熟依赖性许可快速产生 TNF。
PLoS One. 2010 Nov 24;5(11):e15038. doi: 10.1371/journal.pone.0015038.
3
Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses.免疫蛋白酶体亚基 LMP2 在抗病毒体液和先天免疫反应中具有意想不到的作用。
J Exp Clin Cancer Res. 2025 Aug 23;44(1):250. doi: 10.1186/s13046-025-03519-z.
4
From oncogenesis to prognosis: the roles of the immunoproteasome in cancer.从肿瘤发生到预后:免疫蛋白酶体在癌症中的作用
Front Immunol. 2025 Jul 8;16:1603816. doi: 10.3389/fimmu.2025.1603816. eCollection 2025.
5
scFocus: Detecting branching probabilities in single-cell data with SAC.scFocus:使用SAC检测单细胞数据中的分支概率。
Comput Struct Biotechnol J. 2025 May 20;27:2243-2263. doi: 10.1016/j.csbj.2025.04.036. eCollection 2025.
6
PI31 is a positive regulator of 20S immunoproteasome assembly.PI31是20S免疫蛋白酶体组装的正向调节因子。
J Cell Sci. 2025 May 15;138(10). doi: 10.1242/jcs.263887. Epub 2025 May 23.
7
Loss-of-function mutations in the dystonia gene THAP1 impair proteasome function by inhibiting PSMB5 expression.肌张力障碍基因THAP1中的功能丧失突变通过抑制PSMB5的表达损害蛋白酶体功能。
Nat Commun. 2025 Feb 10;16(1):1511. doi: 10.1038/s41467-025-56782-1.
8
Multi-ancestry genome-wide meta-analysis with 472,819 individuals identifies 32 novel risk loci for psoriasis.对472,819名个体进行的多血统全基因组荟萃分析确定了32个新的银屑病风险基因座。
J Transl Med. 2025 Jan 30;23(1):133. doi: 10.1186/s12967-024-06015-8.
9
PI31 is a positive regulator of 20S immunoproteasome assembly.PI31是20S免疫蛋白酶体组装的正向调节因子。
bioRxiv. 2025 Jan 15:2025.01.15.633194. doi: 10.1101/2025.01.15.633194.
10
Association of Proteasome Activity and Pool Heterogeneity with Markers Determining the Molecular Subtypes of Breast Cancer.蛋白酶体活性和库异质性与决定乳腺癌分子亚型的标志物的关联
Cancers (Basel). 2025 Jan 6;17(1):159. doi: 10.3390/cancers17010159.
J Immunol. 2010 Apr 15;184(8):4115-22. doi: 10.4049/jimmunol.0903003. Epub 2010 Mar 12.
4
Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction.利用大规模质谱肽测序和生物信息学预测鉴定C57BL/6小鼠中的天然加工配体。
Immunogenetics. 2009 Mar;61(3):241-6. doi: 10.1007/s00251-009-0360-4. Epub 2009 Feb 18.
5
Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes.加工速率决定了免疫蛋白酶体产生的表位的免疫原性。
J Immunol. 2007 Jun 15;178(12):7557-62. doi: 10.4049/jimmunol.178.12.7557.
6
Immunoproteasome subunit deficiencies impact differentially on two immunodominant influenza virus-specific CD8+ T cell responses.免疫蛋白酶体亚基缺陷对两种免疫显性流感病毒特异性CD8 + T细胞反应产生不同影响。
J Immunol. 2006 Dec 1;177(11):7680-8. doi: 10.4049/jimmunol.177.11.7680.
7
Role of immunoproteasomes in cross-presentation.免疫蛋白酶体在交叉呈递中的作用。
J Immunol. 2006 Jul 15;177(2):983-90. doi: 10.4049/jimmunol.177.2.983.
8
An altered T cell repertoire in MECL-1-deficient mice.MECL-1缺陷小鼠中T细胞库的改变。
J Immunol. 2006 Jun 1;176(11):6665-72. doi: 10.4049/jimmunol.176.11.6665.
9
Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses.蛋白酶体塑造参与抗原特异性免疫反应的T细胞库。
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5042-7. doi: 10.1073/pnas.0509256103. Epub 2006 Mar 20.
10
Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination.免疫蛋白酶体缺陷小鼠对淋巴细胞性脉络丛脑膜炎病毒感染和DNA疫苗接种产生的CD8 + T细胞反应基本正常。
J Immunol. 2005 Jul 15;175(2):1153-60. doi: 10.4049/jimmunol.175.2.1153.